Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells by Tomé, Ângelo R. et al.
Brain Research 903 (2001) 62–65
www.elsevier.com/ locate /bres
Research report
Naloxone inhibits nicotine-induced receptor current and catecholamine
secretion in bovine chromaffin cells
a ,1 b ,1 a b
˜´ ´ ´ ´Angelo R. Tome , Victor Izaguirre , Luıs M. Rosario , Valentın Cena ,
b ,*´ ´Carmen Gonzalez-Garcıa
aDepartment of Biochemistry, Faculty of Sciences and Technology and Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra,
Portugal
b
´ ´Centro Regional de Investigaciones Biomedicas and Departamento de Ciencias Medicas, Facultad de Medicina, Universidad de Castilla-La Mancha,
˜´Edif Benjamın Palencia, Avda. Espana, s /n, E-02071 Albacete, Spain
Accepted 6 March 2001
Abstract
Nicotine-induced catecholamine (CA) secretion and inward ionic currents were inhibited by the opioid antagonist naloxone in cultured
bovine chromaffin cells. Naloxone inhibited nicotine-induced CA secretion, as detected by an on-line real-time electrochemical technique,
in a dose-dependent manner (IC 529 mM). In voltage-clamped chromaffin cells, nicotine (10 mM) evoked an average peak inward50
current of 2146 pA that was inhibited by low concentrations of naloxone (42% at 0.1 mM). The antagonist also inhibited total charge
influx associated with nicotinic receptor activation (53% at 0.1 mM). This provides strong evidence that naloxone modulation of
nicotine-induced CA secretion does not involve opioid receptors but results from the direct interaction with the nicotinic receptor itself,
which might also be the case for other related opioid compounds. Ó 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction but this effect does not seem to be mediated by opioid
receptors since opioid antagonists, like naloxone, have the
Chromaffin cells secrete catecholamines (CA) in re- same effect [8]. Moreover, it has been shown that activa-
21
sponse to different stimuli [17,21]. Under physiological tion of opioid k receptors inhibits nicotine-induced Ca
conditions, acetylcholine is released from splanchnic nerve entry into chromaffin cells but this effect is not prevented
terminals and interacts with nicotinic receptors producing by opioid antagonists like Mr2266 [1].
depolarization of chromaffin cell membrane [18,23]. This Cholinergic nicotinic receptors are targets for an increas-
21depolarization opens voltage-dependent Ca channels ing number of drugs and toxins like dihydropyridines [20],
21[7,11], which produces an increase in intracellular Ca v-agatoxin IVA, a specific blocker of P/Q type voltage-
21 21levels ([Ca ] ) [2,7] and CA and ATP secretion [3,9]. dependent Ca channels [13], the diuretic cyclothiazidei
Bovine chromaffin cells co-release opioid peptides [22] and tricyclic antidepressants [14]. Interaction of these
together with CA following nicotinic receptor stimulation substances with the receptor might interfere with its
[19] and their membranes possess m, d and k opioid function.
receptors [16]. The secreted opioid peptides might inhibit To elucidate the mechanism of action of the inhibition
nicotine-induced CA secretion from chromaffin cells [15], of nicotine-induced CA secretion by opioid antagonists, we
have studied the effect of naloxone, a well known opioid
antagonist, on nicotine-induced CA secretion from
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induced inward currents. We have found that the antagonist After 10 min, nicotine (10 mM) was applied for 4 s using a
is able to inhibit, in a dose-dependent and reversible fast perfusion system under computer control (DAD-12
manner, nicotine-induced CA secretion and inward cur- superfusion system; Adams and List, NY). This nicotine
rents. pulse was repeated three times (S , S , S ) at 15-min1 2 3
intervals. When used, naloxone was perfused 1 s before
and during S .2
2. Materials and methods
2.1. Cell isolation and culture 2.4. Reagents
Bovine chromaffin cells were isolated using collagenase Nicotine and naloxone were obtained from Sigma (St
digestion and purified through a Percoll gradient as Louis, MO) penicillin and streptomycin from Bio-Whit-
previously described [4]. For electrophysiological record- taker Bioproducts (Walkersville, MD) and bovine serum
6ings 10 cells were plated in a 35-mm diameter Petri dish albumin from Calbiochem (La Jolla, CA). All other
(Bibby Science Products, Stone, UK). Cultured cells were reagents were obtained from different commercial sources




Catecholamine secretion experiments were performed as
previously described [20] with minor modifications. Briefl- 3.1. Catecholamine secretion
6y, after 2–4 days of culture, chromaffin cells (ca. 2310
cells) were transferred to a perfusion chamber (a 2.3-mm Introduction of nicotine (10 mM) in the perfusion flow
diameter, 0.8-mm membrane pore, disposable filter unit) resulted in the detection of a transitory CA secretion
and continuously perfused at 2 ml /min with Krebs–Hepes indicating that the agonist induced CA release from the
(K-H) solution with the following composition (in mmol / chromaffin cells present in the perfusion chamber [5]. The
l): NaCl, 140; KCl, 5; CaCl , 2; MgCl , 1, Hepes, 10; and electrochemical signal was equivalent to the release of2 2
6glucose, 5; pH was adjusted to a value between 7.3 and 1.060.3 nmol CA/10 cells (mean6S.E.M., n53). The
7.4. The cell bed was stimulated with nicotine (10 mM) amplitude of the electrochemical signal tended to decrease
every 10 min, beginning after 15 min from the start of as the stimulation of CA secretion with nicotine was
perfusion. The effluent solution exiting the perfusion repeated every 10 min (Fig. 1A). Naloxone produced a
chamber was driven into an electrochemical detector marked decrease in the nicotine-induced secretory epi-
(Omni 90 potentiostat, Cypress Systems, Lawrence, KS, sodes. The inhibitory effect of naloxone on the nicotine-
USA) for direct continuous on-line measurement of cat- induced CA release was dose-dependent. The blockade
echolamine oxidation current (anodic potential set at 1650 was almost complete at the highest drug concentration
mV). When used, naloxone-containing solutions were used, 200 mM (9662% inhibition, n55; Fig. 1, panel A).
perfused 2 min prior to and during nicotine application. The IC for the blocking effect of naloxone, as de-50
The inhibitory effect of naloxone was calculated by termined from the dose–response curve, was 29 mM (Fig.
comparing the area under the curve for the electrochemical 1B).
signal observed in the presence of the drug with the mean
area of the nicotine-induced signals observed before and
after it. All the experiments were performed at room 3.2. Nicotine-induced inward currents
temperature (22–248C).
Nicotine (10 mM) perfusion for 4 s evoked an inward
2.3. Electrophysiological recording current that amounted to 2146627 pA (n519), producing
a total net charge flux of 495656 pC (n519). When the
Recording of chromaffin cell nicotinic receptor-activated exposure to nicotine was repeated 15 min later, the ratio
currents under voltage-clamp was performed, using the S /S for peak current was 0.9460.07 (n55) and for2 1
nystatin-perforated patch-clamp technique, as previously charge influx was 1.0260.09 (n55). The presence of
described [13]. Chromaffin cells were bathed in a solution naloxone during S produced a marked decrease in both2
with the following ionic composition (in mmol / l): NaCl peak current and charge influx that was reversible upon
140; KCl 5.9; MgSO 1.2; CaCl 2.5; Hepes 15 and removal of the drug (Fig. 2). The inhibitory effect of4 2
glucose 11 (pH 7.4). The intracellular solution had the naloxone was dose-dependent. The blockade reached
following composition (in mmol / l): KCl 55; K SO 50; around 65% for peak current and 68% for total charge2 4
MgSO 7; Hepes 10 and nystatin 250 mg/ml (pH 7.2). influx at 10 mM drug concentration (Table 1).4
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Fig. 2. Nicotine-induced inward currents in chromaffin cells. Inward
currents evoked by three successive exposures (S , S , S ; 4 s; 15 min1 2 3
apart) to nicotine (10 mM) from a holding potential of 255 mV. Naloxone
(10 mM) was present 1 s before and during S . The experiment was2
repeated six more times with similar results.
likelihood, has removed the locally secreted products. The
inhibitory mechanism of opioids on nicotine-evoked CA
secretion has been controversial since the lack of stereos-
pecificity [8] and non reversion by opioid antagonists [1,8]
were shown suggesting that specific opioid receptors were
not involved in this action. Our electrophysiological data
Fig. 1. Effect of naloxone on nicotine-induced catecholamine secretion. support this proposal and indicate that the nicotinic
(A) Secretory episodes evoked by consecutive applications of nicotine (10 receptor might be a target through which opioid drugs
mM, 10 min apart) to the perfused chromaffin cell population. The might regulate directly nicotinic receptor-mediated func-
horizontal bars indicate nicotine-induced secretory episodes recorded in
tions. Noteworthy is the fact that the cholinergic nicotinicthe presence of naloxone (naloxone concentrations, in mM, are indicated
receptors from chromaffin cells have been shown tobelow the bars). (B) Dose–response curve for the inhibitory effect of
naloxone on the nicotine-induced CA secretion. Data were calculated as interact with a broad range of unrelated compounds
stated in Material and methods and represent mean6S.E.M. of three [6,12,13,22] indicating that such a process might be a
different experiments. pharmacologically relevant mechanism to regulate
chromaffin cell secretory activity.
In summary, the data presented here suggest that the4. Discussion
non-selective opioid antagonist naloxone blocks nicotine-
induced CA secretion by a direct interaction with nicotinic
The results presented here show that the non-selective
receptors, located on the plasmalemma of chromaffin cells,
opioid antagonist naloxone potently blocks nicotine-in-
duced CA secretion from chromaffin cells and this effect
might be explained by the reversible blockade of nicotine- Table 1
Effect of naloxone on nicotine-induced inward currents and net chargeinduced inward currents in chromaffin cells.
influx in bovine chromaffin cellsChromaffin cells in culture might secrete and accumu-
late in its vicinity different products, including endogenous Drug added together with n Peak current Total net charge
nicotine during S (S /S ratio) influx (S /S ratio)opioids [19], that might produce a negative feedback on 2 2 1 2 1
secretion. Support for this view comes from studies that None 5 0.9460.07 1.0260.09
Naloxone 0.1 mM 7 0.5460.05* 0.4760.06*indicate that cell superfusion resulting in fast removal of
21 Naloxone 10 mM 7 0.3360.03** 0.3360.03**locally secreted products produces an increase in Ca
current amplitude [10]. Our data indicate that this mecha- Bovine chromaffin cells were exposed for 4 s to nicotine (10 mM) as
stated in Material and methods. Nicotine stimulation was repeated threenism is not involved in naloxone effects because, in order
times (S , S , S ) at 15-min intervals. Naloxone was perfused to the cell 11 2 3to prevent tonic modifications of nicotinic receptor-me-
s before and during S . The average values for inward peak current and2diated functions, both the CA secretion studies and electro- total net charge influx during S were 2146627 pA (n519) and 4956561physiological recordings have been performed under con- pC (n519). Data represent mean6S.E.M.
tinuous fast superfusion of chromaffin cells that, in all *P,0.001; **P,0.0001 compared to control.
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and secretion in the adrenal chromaffin cell: extrusion of ATPand that opioid-mediated inhibition of nicotine-evoked CA
(unhydrolysed) during release of catecholamines, J. Physiol. 183secretion is not mediated by specific opioid receptors. (1966) 249–256.
21[10] A. Elhamdani, J.L. Bossu, A. Feltz, Evolution of the Ca current
during dialysis of isolated bovine chromaffin cells: effect of internal
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